Key Record Dates
ClinicalTrials.gov Identifier: | NCT02882282 |
---|---|
Brief Title: | Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia |
First Submitted : | August 24, 2016 |
First Submitted that Met QC Criteria : | August 24, 2016 |
First Posted : | August 29, 2016 (Estimate) |
Last Update Submitted that Met QC Criteria : | April 14, 2023 |
Last Update Posted : | April 18, 2023 |